South Africa's Aspen Pharmacare said on Monday it had agreed to a price of 600 million pounds ($967 million) to buy thrombosis drugs and a factory from shareholder GlaxoSmithKline .

Aspen and Britain's Glaxo first announced the deal in June.

($1 = 0.6203 British pounds)

(Reporting by David Dolan; Editing by Stella Mapenzauswa)